Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation

被引:48
作者
Mellor, HR [1 ]
Platt, FM [1 ]
Dwek, RA [1 ]
Butters, TD [1 ]
机构
[1] Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England
关键词
amphiphilic; ceramide; cytotoxicity; detergent; glucosyltransferase; imino sugar;
D O I
10.1042/BJ20030348
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The N-alkyl moiety of N-alkylated imino sugars is crucial for therapeutic activities of these compounds as inhibitors of glycosphingolipid (GSL) biosynthesis and as antivirals. The improved potency afforded by a long N-alkyl moiety is coincident with increased compound-induced cytotoxicity. Therefore, in the present study, we examined the mechanism of this cytotoxicity in detail. Despite N-butyl-deoxynojirimycin and N-butyl-deoxygalactonojirimycin inhibiting the glycosylation of ceramide to glucosylceramide, ceramide levels did not increase in HL60 cells treated with these compounds. Long-chain N-alkylated imino sugars were toxic to cells at concentrations considerably lower than the critical micellar concentrations for these compounds and consequently did not solubilize radioactively labelled cellular proteins and lipids. However, membrane disruption and cell fragmentation did increase in a concentration- and chain-length-dependent manner. These results are consistent with previously proposed interactions between surface-active amphiphiles and protein-containing lipid membranes when drug concentrations are below the critical micellar concentration. Taken together, these results demonstrate that the cellular toxicity of hydrophobic N-alkylated imino Sugars is due to cell lysis and cell fragmentation and, most importantly, is not related to the beneficial therapeutic effects of these compounds on protein and in lipid glycosylation. This information will aid in the future development of more selective imino sugar therapeutics for the treatment of human disease.
引用
收藏
页码:307 / 314
页数:8
相关论文
共 35 条
[1]   A novel enzyme that catalyzes the esterification of N-acetylsphingosine - Metabolism of C-2-ceramides [J].
Abe, A ;
Shayman, JA ;
Radin, NS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14383-14389
[2]   N-butyldeoxygalactonojirimycin:: A more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo [J].
Andersson, U ;
Butters, TD ;
Dwek, RA ;
Platt, FM .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (07) :821-829
[3]  
BETTS JC, 1994, J BIOL CHEM, V269, P8455
[4]   N-acylated serinol is a novel ceramide mimic inducing apoptosis in neuroblastoma cells [J].
Bieberich, E ;
Kawaguchi, T ;
Yu, RK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :177-181
[5]   Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells [J].
Bieberich, E ;
Freischütz, B ;
Suzuki, M ;
Yu, RK .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) :1040-1049
[6]   Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking [J].
Block, TM ;
Lu, XY ;
Mehta, AS ;
Blumberg, BS ;
Tennant, B ;
Ebling, M ;
Korba, B ;
Lansky, DM ;
Jacob, GS ;
Dwek, RA .
NATURE MEDICINE, 1998, 4 (05) :610-614
[7]   Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers [J].
Branza-Nichita, N ;
Durantel, D ;
Carrouée-Durantel, S ;
Dwek, RA ;
Zitzmann, N .
JOURNAL OF VIROLOGY, 2001, 75 (08) :3527-3536
[8]   Structure and function of sphingolipid- and cholesterol-rich membrane rafts [J].
Brown, DA ;
London, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) :17221-17224
[9]   Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis [J].
Butters, TD ;
van den Broek, LAGM ;
Fleet, GWJ ;
Krulle, TM ;
Wormald, MR ;
Dwek, RA ;
Platt, FM .
TETRAHEDRON-ASYMMETRY, 2000, 11 (01) :113-124
[10]   Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis [J].
Cox, T ;
Lachmann, R ;
Hollak, C ;
Aerts, J ;
van Weely, S ;
Hrebícek, M ;
Platt, F ;
Butters, T ;
Dwek, R ;
Moyses, C ;
Gow, I ;
Elstein, D ;
Zimran, A .
LANCET, 2000, 355 (9214) :1481-1485